Sai Ma

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Aortic Stenosis

Top Venues

Drug design, development and therapy

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Qingjuan Zuo, Guorui Zhang, Lili He, Sai Ma, Huijuan Ma, Jianlong Zhai, Zhongli Wang, Tingting Zhang, Yan Wang, Yifang Guo
Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice. Drug design, development and therapy 16 (2022)
Sai Ma, Li-Li He, Guo-Rui Zhang, Qing-Juan Zuo, Zhong-Li Wang, Jian-Long Zhai, Ting-Ting Zhang, Yan Wang, Hui-Juan Ma, Yi-Fang Guo
Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction. Naunyn-Schmiedeberg's archives of pharmacology 395 (8) (2022)
Qingjuan Zuo, Guorui Zhang, Lili He, Sai Ma, Huijuan Ma, Jianlong Zhai, Zhongli Wang, Tingting Zhang, Yan Wang, Yifang Guo
Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice. Drug design, development and therapy 16 (2022)